Amy D Shapiro
Indiana Hemophilia and Thrombosis Center, Inc · Indiana Hemophilia &Thrombosis Center, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Amy D Shapiro as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:29 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT05317806 · Metformin Use in Cardiac Fibrosis in PAI-1 DeficiencyIndiana Hemophilia &Thrombosis Center, Inc. · active not recruiting · Plasminogen Activator Inhibitor-1 Deficiency, Cardiac Fibrosis · study director
- Ph4NCT04567511 · Hemlibra in Mild Hemophilia AIndiana Hemophilia &Thrombosis Center, Inc. · recruiting · Factor VIII Deficiency, Congenital · principal investigator
- Ph4NCT03921294 · HemLibra Prophylaxis in Patients With Hemophilic PseudotumorIndiana Hemophilia &Thrombosis Center, Inc. · terminated · Haemophilic Pseudotumour · principal investigator
- N/ANCT03797495 · Study of Individuals Affected With HypoplasminogenemiaIndiana Hemophilia &Thrombosis Center, Inc. · recruiting · Plasminogen Deficiency · principal investigator
- N/ANCT02502409 · Natural History Study of Factor IX Treatment and ComplicationsSkane University Hospital · unknown · Factor IX Deficiency · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- PHASE I/II STUDY IN PREVIOUSLY TREATED SEVERE HEMOPHILIA BM01RR000750 · NCRR · INDIANA UNIVERSITY INDIANAPOLIS · fiscal years 1996 to 1999 · $16,973 awarded in 1999Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:29 UTC. The ranking covers the 200 most relevant of 24 PubMed records, and a shared surname and initials can bring in a namesake. All 24 on PubMed
- Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.N Engl J Med · 20071,584 citationsRCR 46.7
- Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery.Thromb Haemost · 1998323 citationsRCR 11.7
- Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.Thromb Haemost · 1998301 citationsRCR 11.2
- 139 citationsRCR 4.9
- 127 citationsRCR 3.8
- 119 citationsRCR 6.6
- BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A.N Engl J Med · 2020118 citationsRCR 7.4
- Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.N Engl J Med · 202492 citationsRCR 12.9
- Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study.Lancet Haematol · 202384 citationsRCR 13.9
- 79 citationsRCR 2.7